GLG LLC’s Bellicum Pharmaceuticals, Inc. BLCM Stock Holding History

GLG LLC’s Portfolio BLCM Stock Details BLCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-8,209	Closed	-$1.75M	–	635
2015 Q2	$1.75M	Buy	8,209 +432	+6%	+$106K	0.04%	374
2015 Q1	$1.8M	Buy	+7,777	New	+$1.88M	0.05%	341

Other funds holding BLCM

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

GLG LLC's BLCM Position: Q3 2015 in Review

GLG LLC sold out of Bellicum Pharmaceuticals, Inc. (BLCM) in Q3 2015, closing a stake of 8,209 shares — an estimated $1.75M sold.

GLG LLC first reported a position in BLCM in Q1 2015 and held it in 2 quarters. The position peaked at $1.8M in Q1 2015. 83 funds tracked by Wall St. Rank hold BLCM as of Q3 2015.

GLG LLC reported no remaining Bellicum Pharmaceuticals, Inc. position as of Q3 2015 after selling out during the quarter.
GLG LLC sold 8,209 Bellicum Pharmaceuticals, Inc. shares in Q3 2015, an estimated $1.75M.
GLG LLC first reported a position in Bellicum Pharmaceuticals, Inc. in Q1 2015 and held it in 2 quarters.
GLG LLC's Bellicum Pharmaceuticals, Inc. position peaked at $1.8M in Q1 2015.
83 funds tracked by Wall St. Rank held Bellicum Pharmaceuticals, Inc. as of Q3 2015.

Based on GLG LLC's 13F filing for Q3 2015, filed 16 Nov 2015.